News and Trends 25 Jul 2023
Molecure raises $12M and gets FDA clearance for pulmonary sarcoidosis trial
Molecure S.A. has received clearance from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) application to conduct phase II clinical testing of OATD-01. The announcement…